Mo H, Yue P, Li Q, Tan Y, Yan X, Liu X
Angiogenesis. 2025; 28(2):14.
PMID: 39899173
DOI: 10.1007/s10456-025-09969-5.
Villanueva C, Tripathi D, Bosch J
Nat Rev Gastroenterol Hepatol. 2025; .
PMID: 39870944
DOI: 10.1038/s41575-024-01031-x.
Dong Z, Wang Y, Jin W
MedComm (2020). 2024; 5(10):e721.
PMID: 39290252
PMC: 11406049.
DOI: 10.1002/mco2.721.
Zhang S, Chen Z, Jiang X, Zhou S, Liu Y, Liu M
Front Public Health. 2024; 12:1383065.
PMID: 38989121
PMC: 11233708.
DOI: 10.3389/fpubh.2024.1383065.
Nimri F, Ichkhanian Y, Shinn B, Kowalski T, Loren D, Kumar A
Endosc Int Open. 2024; 12(6):E740-E749.
PMID: 38847015
PMC: 11156515.
DOI: 10.1055/a-2312-1528.
Metformin and the Liver: Unlocking the Full Therapeutic Potential.
Perazza F, Leoni L, Colosimo S, Musio A, Bocedi G, DAvino M
Metabolites. 2024; 14(4).
PMID: 38668314
PMC: 11052067.
DOI: 10.3390/metabo14040186.
Gut-Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers.
Lombardi M, Troisi J, Motta B, Torre P, Masarone M, Persico M
Nutrients. 2024; 16(7).
PMID: 38613058
PMC: 11013091.
DOI: 10.3390/nu16071025.
Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives.
De Gaetano V, Pallozzi M, Cerrito L, Santopaolo F, Stella L, Gasbarrini A
Cancers (Basel). 2024; 16(7).
PMID: 38611066
PMC: 11011056.
DOI: 10.3390/cancers16071388.
Can Endothelin-1 Levels in Patients with Esophageal Variceal Bleeding at Admission Predict Rebleeding Within 5 Days?.
Shaltout S, Messery A, Elshabrawi A, Amin A, H Elshennawy M, Ibrahim Mortada M
Turk J Gastroenterol. 2024; 35(2):136-142.
PMID: 38454245
PMC: 10895874.
DOI: 10.5152/tjg.2024.23028.
Recent Approaches in Portal Hypertension Involving Risk Stratification and Medical Management.
Patel M, Hunt C, VanWagner L
Gastroenterol Hepatol (N Y). 2024; 19(11):662-669.
PMID: 38405225
PMC: 10882863.
Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges.
Madir A, Grgurevic I, Tsochatzis E, Pinzani M
World J Gastroenterol. 2024; 30(4):290-307.
PMID: 38313235
PMC: 10835535.
DOI: 10.3748/wjg.v30.i4.290.
Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis-Pathogenesis, Implications and Therapeutic Opportunities.
Terbah R, Testro A, Gow P, Majumdar A, Sinclair M
Nutrients. 2024; 16(1).
PMID: 38201864
PMC: 10780673.
DOI: 10.3390/nu16010035.
A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol.
Nasr P, Forsgren M, Balkhed W, Jonsson C, Dahlstrom N, Simonsson C
BMC Gastroenterol. 2023; 23(1):454.
PMID: 38129794
PMC: 10734181.
DOI: 10.1186/s12876-023-03093-8.
Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease.
Kotani K, Kawada N
Gut Liver. 2023; 18(1):27-39.
PMID: 37842727
PMC: 10791512.
DOI: 10.5009/gnl230072.
Mechanobiology of portal hypertension.
Felli E, Selicean S, Guixe-Muntet S, Wang C, Bosch J, Berzigotti A
JHEP Rep. 2023; 5(11):100869.
PMID: 37841641
PMC: 10568428.
DOI: 10.1016/j.jhepr.2023.100869.
Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells.
Wu Y, Yin A, Sun J, Xu W, Zhang C
World J Gastroenterol. 2023; 29(33):4975-4990.
PMID: 37732000
PMC: 10507507.
DOI: 10.3748/wjg.v29.i33.4975.
Oit3, a promising hallmark gene for targeting liver sinusoidal endothelial cells.
Li Z, Ruan B, Yang P, Liu J, Song P, Duan J
Signal Transduct Target Ther. 2023; 8(1):344.
PMID: 37696816
PMC: 10495338.
DOI: 10.1038/s41392-023-01621-2.
Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis.
Giuli L, Pallozzi M, Venturini G, Gasbarrini A, Ponziani F, Santopaolo F
Int J Mol Sci. 2023; 24(16).
PMID: 37628933
PMC: 10454315.
DOI: 10.3390/ijms241612754.
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome.
Simbrunner B, Villesen I, Scheiner B, Paternostro R, Schwabl P, Stattermayer A
Hepatol Int. 2023; 17(6):1532-1544.
PMID: 37605068
PMC: 10661794.
DOI: 10.1007/s12072-023-10577-y.
Systemic Complications Secondary to Chronic Liver Disease.
Mannion R, Fitzpatrick E
Indian J Pediatr. 2023; 91(3):286-293.
PMID: 37440151
PMC: 10866760.
DOI: 10.1007/s12098-023-04694-7.
